×
About 523 results

ALLMedicine™ Kaposiform Hemangioendothelioma Center

Research & Reviews  261 results

Kaposiform Hemangioendothelioma: clinicopathological characteristics of 8 cases of a ra...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962213
Diagnostic Pathology; Chundriger Q, Tariq MU et. al.

Mar 16th, 2021 - Kaposiform Hemangioendothelioma (KHE) is a rare vascular tumor of intermediate malignant potential which shows locally aggressive growth but only rarely metastasizes. It is mostly considered to be a tumor of pediatric population but its occurrence...

Vascular Anomalies of the Head and Neck: A Pediatric Overview.
https://doi.org/10.1007/s12105-020-01236-x 10.1177/1179545X17699849
Head and Neck Pathology; Putra J, Al-Ibraheemi A

Mar 16th, 2021 - Vascular anomalies, further classified into vascular tumors and malformations, often involve the head and neck region of children. These entities may raise diagnostic dilemmas, as they often demonstrate heterogenous and overlapping histologic feat...

Comparison of efficacy and safety of corticosteroid and vincristine in treating kaposif...
https://doi.org/10.1111/1346-8138.15767
The Journal of Dermatology; Yao W, Li K et. al.

Feb 20th, 2021 - Kaposiform haemangioendothelioma (KHE) and tufted angioma (TA) are rare vascular tumors that can cause life-threatening Kasabach-Merritt phenomenon. No evidence-based treatment strategies have yet been established, and its management is still a ch...

Additive value of transarterial embolization to systemic sirolimus treatment in kaposif...
https://doi.org/10.1002/ijc.33406
International Journal of Cancer; Brill R, Uller W et. al.

Nov 24th, 2020 - Kaposiform hemangioendothelioma (KHE) is a rare vascular tumor in children, which can be accompanied by life-threatening thrombocytopenia, referred to as Kasabach-Merritt phenomenon (KMP). The mTOR inhibitor sirolimus is emerging as targeted thera...

see more →

Clinicaltrials.gov  261 results

Kaposiform Hemangioendothelioma: clinicopathological characteristics of 8 cases of a ra...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962213
Diagnostic Pathology; Chundriger Q, Tariq MU et. al.

Mar 16th, 2021 - Kaposiform Hemangioendothelioma (KHE) is a rare vascular tumor of intermediate malignant potential which shows locally aggressive growth but only rarely metastasizes. It is mostly considered to be a tumor of pediatric population but its occurrence...

Vascular Anomalies of the Head and Neck: A Pediatric Overview.
https://doi.org/10.1007/s12105-020-01236-x 10.1177/1179545X17699849
Head and Neck Pathology; Putra J, Al-Ibraheemi A

Mar 16th, 2021 - Vascular anomalies, further classified into vascular tumors and malformations, often involve the head and neck region of children. These entities may raise diagnostic dilemmas, as they often demonstrate heterogenous and overlapping histologic feat...

Comparison of efficacy and safety of corticosteroid and vincristine in treating kaposif...
https://doi.org/10.1111/1346-8138.15767
The Journal of Dermatology; Yao W, Li K et. al.

Feb 20th, 2021 - Kaposiform haemangioendothelioma (KHE) and tufted angioma (TA) are rare vascular tumors that can cause life-threatening Kasabach-Merritt phenomenon. No evidence-based treatment strategies have yet been established, and its management is still a ch...

Additive value of transarterial embolization to systemic sirolimus treatment in kaposif...
https://doi.org/10.1002/ijc.33406
International Journal of Cancer; Brill R, Uller W et. al.

Nov 24th, 2020 - Kaposiform hemangioendothelioma (KHE) is a rare vascular tumor in children, which can be accompanied by life-threatening thrombocytopenia, referred to as Kasabach-Merritt phenomenon (KMP). The mTOR inhibitor sirolimus is emerging as targeted thera...

see more →